Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,675.00p
   
  • Change Today:
    -25.00p
  • 52 Week High: 4,500.00p
  • 52 Week Low: 2,350.00p
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 16,582
  • Market Cap: £139.77m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
21.73% below the market average21.73% below the market average21.73% below the market average21.73% below the market average21.73% below the market average
40% below the sector average40% below the sector average40% below the sector average40% below the sector average40% below the sector average
1yr Revenue Growth
11.17% above the market average11.17% above the market average11.17% above the market average11.17% above the market average11.17% above the market average
16.13% below the sector average16.13% below the sector average16.13% below the sector average16.13% below the sector average16.13% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
48.02% above the market average48.02% above the market average48.02% above the market average48.02% above the market average48.02% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
1yr DPS Growth
37.14% below the market average37.14% below the market average37.14% below the market average37.14% below the market average37.14% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
40.10% above the market average40.10% above the market average40.10% above the market average40.10% above the market average40.10% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Price Book Ratio
93.8% below the market average93.8% below the market average93.8% below the market average93.8% below the market average93.8% below the market average
70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
68.71% above the market average68.71% above the market average68.71% above the market average68.71% above the market average68.71% above the market average
41.67% above the sector average41.67% above the sector average41.67% above the sector average41.67% above the sector average41.67% above the sector average
Price Chg 3m
46.99% below the market average46.99% below the market average46.99% below the market average46.99% below the market average46.99% below the market average
Sector averageSector averageSector averageSector averageSector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
71.12% above the market average71.12% above the market average71.12% above the market average71.12% above the market average71.12% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average
Momentum 20
96.52% above the market average96.52% above the market average96.52% above the market average96.52% above the market average96.52% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
74.67% above the market average74.67% above the market average74.67% above the market average74.67% above the market average74.67% above the market average
94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average94.29% above the sector average
ROCE
79.44% above the market average79.44% above the market average79.44% above the market average79.44% above the market average79.44% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
91.46% above the market average91.46% above the market average91.46% above the market average91.46% above the market average91.46% above the market average
87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average
Forecast EPS
76.80% above the market average76.80% above the market average76.80% above the market average76.80% above the market average76.80% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
35.1% below the market average35.1% below the market average35.1% below the market average35.1% below the market average35.1% below the market average
2.86% below the sector average2.86% below the sector average2.86% below the sector average2.86% below the sector average2.86% below the sector average
Operating Profit Loss
26.06% above the market average26.06% above the market average26.06% above the market average26.06% above the market average26.06% above the market average
79.17% above the sector average79.17% above the sector average79.17% above the sector average79.17% above the sector average79.17% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
24.25% below the market average24.25% below the market average24.25% below the market average24.25% below the market average24.25% below the market average
14.89% above the sector average14.89% above the sector average14.89% above the sector average14.89% above the sector average14.89% above the sector average
Cash
10.14% below the market average10.14% below the market average10.14% below the market average10.14% below the market average10.14% below the market average
2.13% above the sector average2.13% above the sector average2.13% above the sector average2.13% above the sector average2.13% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
76.03% below the market average76.03% below the market average76.03% below the market average76.03% below the market average76.03% below the market average
85.19% below the sector average85.19% below the sector average85.19% below the sector average85.19% below the sector average85.19% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,675.00p
Change Today -25.00p
% Change -0.93 %
52 Week High 4,500.00p
52 Week Low 2,350.00p
Volume 16,582
Shares Issued 5.22m
Market Cap £139.77m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
11.02% below the market average11.02% below the market average11.02% below the market average11.02% below the market average11.02% below the market average
54.17% above the sector average54.17% above the sector average54.17% above the sector average54.17% above the sector average54.17% above the sector average
Price Trend
61.45% below the market average61.45% below the market average61.45% below the market average61.45% below the market average61.45% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Income
46.27% above the market average46.27% above the market average46.27% above the market average46.27% above the market average46.27% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
21.91% below the market average21.91% below the market average21.91% below the market average21.91% below the market average21.91% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 02-May-2025

Time Volume / Share Price
16:03 3,100 @ 2,725.00p
16:25 915 @ 2,692.00p
15:19 1,000 @ 2,725.00p
15:17 1,225 @ 2,745.00p
16:10 17 @ 2,748.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page